Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops

MDbackline

Status: Completed

Conditions: Glaucoma

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02138461

JH-ALG-MDB-1301

Details and patient eligibility

About

This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.

Full description

Patients enrolled in this study completed a validated survey instrument (COMTOL) examining tolerability of topically applied ophthalmic medications that they are already taking in their regular course of care for glaucoma. The purpose of the study is to determine whether side effects and symptoms of the drugs already being taken cause problems with activities of daily living.

Enrollment: 211 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with glaucoma taking either bimatoprost or latanoprost

Exclusion criteria

• patients taking other medication or with other causes for ocular surface symptoms

Trial design

211 participants in 2 patient groups

bimatoprost

Description:

These patients take bimatoprost topically for glaucoma.

latanoprost group

Description:

These patients take latanoprost topically for glaucoma.